Accord Logo

Intended for UK patients and members of the public

Co-codamol Tablets BP 8/500mg

Co-codamol Tablets BP 8/500mg

PL Number:
0142/0197
MA Holder:
Accord-UK Ltd
Product Classification:
P
Product Status:
Active

Product Documentation

  • Description of update:

    1: To update SmPC sections 4.2 and 4.4 and PIL section 3 in line with the MHRA letter (Annex 1) - review of the CMDh recommended warnings for Opioid Use Disorder (OUD).

    2: To update SmPC sections 4.4, 4.5, 4.8 and PIL sections 2, 4 and 5 in line with PSUSA/00000851/202503 for codeine/paracetamol containing medicines to include the

    following information: interactions with gabapentinoids, Sphincter of Oddi dysfunction, hyperalgesia, central sleep apnoea (CSA), opioid drug disorder (OUD), storage information.

    Date of approval: 30/04/2026

    PIL sections updated: Introduction, 2, 3, 4, 5 and 6

  • Description of update:

    1: To update SmPC sections 4.2 and 4.4 and PIL section 3 in line with the MHRA letter (Annex 1) - review of the CMDh recommended warnings for Opioid Use Disorder (OUD).

    2: To update SmPC sections 4.4, 4.5, 4.8 and PIL sections 2, 4 and 5 in line with PSUSA/00000851/202503 for codeine/paracetamol containing medicines to include the following information: interactions with gabapentinoids, Sphincter of Oddi dysfunction, hyperalgesia, central sleep apnoea (CSA), opioid drug disorder (OUD), storage information.

    Date of approval: 30/04/2026

    SmPC sections updated: 4.2, 4.4, 4.5, 4.8 and 10

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

For any further assistance, please get in touch.

View product information as a: